These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11781820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB, Roumiantsev S, Van Etten RA.
    Oncogene; 2001 Nov 22; 20(53):7744-52. PubMed ID: 11753652
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S, Wang Y, Kern FG, Qu Z, Li R.
    Proteins; 2007 May 15; 67(3):709-19. PubMed ID: 17335005
    [Abstract] [Full Text] [Related]

  • 7. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
    Buffa P, Manzella L, Consoli ML, Messina A, Vigneri P.
    Proteins; 2007 Apr 01; 67(1):1-11. PubMed ID: 17211892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T.
    Oncogene; 2008 Aug 07; 27(34):4678-89. PubMed ID: 18427551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Cowan-Jacob SW, Fendrich G, Manley PW, Jahnke W, Fabbro D, Liebetanz J, Meyer T.
    Structure; 2005 Jun 07; 13(6):861-71. PubMed ID: 15939018
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
    Schulte RJ, Sefton BM.
    Biochemistry; 2003 Aug 12; 42(31):9424-30. PubMed ID: 12899629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms.
    Dorey K, Barilá D, Gavin AC, Nebreda AR, Superti-Furga G.
    Biol Chem; 1999 Feb 12; 380(2):223-30. PubMed ID: 10195429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH, Pendergast AM, Zipfel PA, Traugh JA.
    Biochemistry; 2008 Jan 22; 47(3):1094-104. PubMed ID: 18161990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.